[HTML][HTML] Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

V Gupta, M Eapen, R Brazauskas, J Carreras… - …, 2010 - ncbi.nlm.nih.gov
V Gupta, M Eapen, R Brazauskas, J Carreras, M Aljurf, RP Gale, GA Hale, O Ilhan…
Haematologica, 2010ncbi.nlm.nih.gov
Background Transplantation from an HLA-matched sibling is the treatment of choice for
young patients with acquired severe aplastic anemia. For older patients, the acceptable
upper age limit for transplantation as first-line treatment varies. The current analysis,
therefore, sought to identify age or ages at transplantation at which survival differed.
Abstract
Background
Transplantation from an HLA-matched sibling is the treatment of choice for young patients with acquired severe aplastic anemia. For older patients, the acceptable upper age limit for transplantation as first-line treatment varies. The current analysis, therefore, sought to identify age or ages at transplantation at which survival differed.
ncbi.nlm.nih.gov